Press release
Glycan Analysis Market to Reach USD 1.36 Billion by 2034, Growing at 9.8% CAGR
Glycan Analysis Market
Glycan analysis is a critical tool in biotechnology and pharmaceuticals, enabling detailed study of carbohydrate structures (glycans) that play vital roles in protein folding, stability, and cell signaling. Glycans are central to understanding disease mechanisms, developing biologics, and ensuring product safety and efficacy in biopharmaceutical manufacturing.
With the rise of monoclonal antibodies, biosimilars, vaccines, and cell & gene therapies, glycan profiling has become indispensable for quality control, biomarker discovery, and therapeutic innovation. As research in precision medicine, oncology, and rare diseases expands, the glycan analysis market is gaining significant traction.
In 2024, the global glycan analysis market is valued at USD 522 million and is projected to reach USD 1.36 billion by 2034, growing at a CAGR of 9.8%.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72860
Market Overview
• Market Size 2024: USD 522 million
• Forecast 2034: USD 1.36 billion
• CAGR (2025-2034): 9.8%
Key Drivers
• Rising adoption of glycan profiling in biopharmaceutical development and manufacturing.
• Increasing demand for quality assurance in monoclonal antibodies and biosimilars.
• Growth in biomarker discovery and precision medicine applications.
• Expansion of research in oncology, autoimmune, and infectious diseases.
• Technological advancements in mass spectrometry, HPLC, and capillary electrophoresis.
Key Challenges
• High cost and complexity of glycan analysis instruments and techniques.
• Lack of standardization across laboratories.
• Limited skilled workforce in advanced glycomics research.
• Data interpretation challenges due to glycan structural diversity.
Leading Players
Agilent Technologies, Thermo Fisher Scientific, Shimadzu Corporation, Bruker, Waters Corporation, New England Biolabs, GlycoSeQuant, Ludger Ltd., ProZyme (Agilent), and SGS Life Sciences.
Segmentation Analysis
By Technique
• Mass Spectrometry (MS)
• High-Performance Liquid Chromatography (HPLC)
• Capillary Electrophoresis (CE)
• Lectin Arrays
• Others (enzymatic & immunoassays)
By Application
• Drug Discovery & Development
• Biopharmaceutical Manufacturing (mAbs, biosimilars, vaccines)
• Biomarker Discovery & Disease Diagnostics
• Academic & Clinical Research
• Quality Control & Regulatory Compliance
By End User
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Clinical Laboratories
Summary:
Mass spectrometry and HPLC dominate the market due to their accuracy and widespread use in biopharma QC. Biopharmaceutical manufacturing is the largest application segment, while biomarker discovery is projected to be the fastest-growing area.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72860/glycan-analysis-market
Regional Analysis
• North America
Leads the market with strong biopharmaceutical pipelines, robust R&D investment, and advanced analytical infrastructure. The U.S. dominates, supported by regulatory requirements for biologics.
• Europe
Significant share driven by biotech clusters in Germany, the UK, and Switzerland. EU regulations on biosimilars and biologics ensure high adoption of glycan analysis.
• Asia-Pacific
Expected to record the fastest growth due to expanding biopharma manufacturing in China, India, South Korea, and Japan. Rising government investment in biologics and vaccine production fuels demand.
• Middle East & Africa
Moderate adoption, though research collaborations and increasing biologics imports are creating growth opportunities.
• Latin America
Brazil and Mexico are regional leaders, with growing biopharma industries and participation in clinical research.
Summary:
North America and Europe dominate today, while Asia-Pacific is projected to outpace them in CAGR due to its rapidly expanding biomanufacturing and clinical trial ecosystem.
Market Dynamics
Growth Drivers
1. Expanding role of glycan analysis in biologics and biosimilars.
2. Rising investment in precision medicine and biomarker discovery.
3. Advances in analytical technologies improving accuracy and throughput.
4. Strong regulatory emphasis on glycan profiling in QC for therapeutic approvals.
5. Increased outsourcing to CROs for advanced glycan studies.
Challenges
• High cost of advanced analytical instruments.
• Complex data interpretation limiting broader adoption.
• Shortage of skilled professionals in glycomics.
• Need for standardized global protocols.
Latest Trends
• Integration of AI and machine learning for glycan data interpretation.
• Development of high-throughput glycomics platforms for faster QC.
• Rising use of glycan biomarkers in oncology and autoimmune diagnostics.
• Increasing partnerships between pharma companies and CROs for glycan profiling.
• Growth of single-cell glycomics as an emerging research frontier.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72862
Competitor Analysis
Key Players
• Agilent Technologies
• Thermo Fisher Scientific
• Shimadzu Corporation
• Bruker
• Waters Corporation
• New England Biolabs
• GlycoSeQuant
• Ludger Ltd.
• ProZyme (Agilent)
• SGS Life Sciences
Competitive Landscape
The market is moderately consolidated, with major analytical instrument providers like Agilent, Thermo Fisher, Waters, and Bruker dominating. Smaller specialized firms such as Ludger and GlycoSeQuant are carving niches in glycomics solutions. Strategic partnerships with pharma and biotech companies are shaping competitive advantage.
Conclusion
The glycan analysis market is gaining prominence as biologics and personalized medicine reshape global healthcare. Valued at USD 522 million in 2024, it is forecasted to reach USD 1.36 billion by 2034, growing at a CAGR of 9.8%.
Opportunities lie in expanding high-throughput analytical platforms, integrating AI for complex data analysis, and growing collaborations between CROs and biopharma firms. Companies that focus on innovation, affordability, and scalability will be well-positioned to lead this fast-evolving market.
This report is also available in the following languages : Japanese (グリカン分析), Korean (글리칸 분석), Chinese (聚糖分析), French (Analyse des glycanes), German (Glykananalyse), and Italian (Analisi dei glicani), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72860
Our More Reports:
Cancer Therapeutics
https://exactitudeconsultancy.com/reports/73150/cancer-therapeutics-market
Oral Proteins and Peptides
https://exactitudeconsultancy.com/reports/73152/oral-proteins-and-peptides-market
Back of the Eye Disorders
https://exactitudeconsultancy.com/reports/73154/back-of-the-eye-disorders-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glycan Analysis Market to Reach USD 1.36 Billion by 2034, Growing at 9.8% CAGR here
News-ID: 4204233 • Views: …
More Releases from Exactitude Consultancy
Alnylam and Ionis Pharmaceuticals are the leading companies in the RNA-targeted …
RNA-targeted therapeutics represent one of the most revolutionary breakthroughs in modern medicine. Unlike traditional drugs that focus primarily on proteins, these therapies act directly at the RNA level, enabling scientists to silence, replace, or modify faulty genetic instructions. This approach provides a powerful platform for treating genetic disorders, cancers, infectious diseases, and rare conditions that were previously considered untreatable.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72683
With the global…
Lipid CMO Market to Reach USD 4.9 Billion by 2034, Growing at 15.0% CAGR
Introduction
Lipids have become a critical component of modern pharmaceutical and biotechnology development, particularly as delivery systems for vaccines, nucleic acid therapies, and innovative biologics. The success of lipid nanoparticles (LNPs) in delivering mRNA COVID-19 vaccines has accelerated global demand for lipid manufacturing expertise, positioning Contract Manufacturing Organizations (CMOs) as essential partners for pharma and biotech firms.
The lipid CMO market is expanding rapidly, supported by increasing investment in gene therapies, RNA-based…
HER2 therapy market is expected to grow to $33.7 billion by 2034. Crucial Partic …
Breast cancer remains one of the most common cancers worldwide, and approximately 15-20% of breast cancers are driven by the overexpression of the human epidermal growth factor receptor 2 (HER2) protein. This condition is more aggressive than HER2-negative cancers but has become highly treatable due to the development of targeted therapies. Beyond breast cancer, HER2 overexpression is also seen in gastric, colorectal, and lung cancers, making HER2 therapies an essential…
Amnesia Market to Reach USD 8.9 Billion by 2034, Expanding Growing at 6.6% CAGR
Introduction
Amnesia, characterized by partial or complete memory loss, can result from brain injury, stroke, dementia, psychological trauma, substance abuse, or neurodegenerative diseases such as Alzheimer's. While traditionally associated with aging, amnesia is increasingly recognized across all age groups due to traumatic brain injuries, mental health disorders, and substance-related complications.
Growing awareness of neurological health, advances in neuroimaging, and the rise of cognitive rehabilitation therapies are driving innovation in this space. Pharmaceutical…
More Releases for USD
Chlorella Market Reach USD 465.85 Million USD by 2030
Market Growth Fueled by Increased Adoption of Plant-Based Proteins and Health Supplements
Global Chlorella Market size was valued at USD 303.75 Mn. in 2023 and the total Chlorella revenue is expected to grow by 6.3 % from 2024 to 2030, reaching nearly USD 465.85 Mn. . The growth of the market is majorly due to increase in the consumer awareness about health, the inclination towards plant-based food such as chlorella and…
Bamboo Clothing Market: USD 1.83B to USD 3.27B by 2030
Bamboo Clothing Market Poised for Robust Growth with Sustainability and Eco-Friendly Trends Driving Demand
The global bamboo clothing market is experiencing substantial growth, spurred by a significant shift towards sustainable fashion and eco-friendly materials. As consumers become increasingly conscious of their environmental impact, bamboo fabric-known for its natural, biodegradable properties-is gaining popularity in the fashion industry. This market is expected to continue its upward trajectory, driven by rising demand for eco-conscious…
Biometrics Market: "Biometrics: USD 34.3B to USD 112.4B by 2031"
Biometrics Market Market Scope:
Key Insights : Biometrics Market size was valued at USD 34.3 billion in 2022 and is poised to grow from USD 39.1 billion in 2023 to USD 112.4 billion by 2031, growing at a CAGR of 14.1% during the forecast period (2024-2031).
Discover Your Competitive Edge with a Free Sample Report :https://www.skyquestt.com/sample-request/biometrics-market
Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/biometrics-market
In-Depth Exploration of the global Biometrics…
Advanced (3D/4D) Visualization Systems Market Size, Trends, Growth, Share to sur …
Fatpos Global has carefully studied specific areas, such as application and product type, in the global Advanced (3D/4D) Visualization Systems Market research study. During the predicted period of 2022 to 2032, each kind gives data on sales. The Advanced (3D/4D) Visualization Systems Market analysis examines into the characteristics and financials of the leading participants.
As per the analysis research report, the Advanced (3D/4D) Visualization Systems Market to…
$100,000,000 USD job contract for travel - $3,000,000 USD referral commission.
Khoja Consultants invites companies, teams or venture capitalists for a $100,000,000 USD contract for travel. The selected company will be providing all accommodations and expenses for a 6-month long business trip around the world. Khoja Consultants expects five-star treatment including close security with private planes, hotels, secured vehicles and helicopters if necessary. More details on the job contract and application are provided at - www.KhojaConsultants.com.
There is a $3,000,000…
IOT Solutions Market worth USD 553.9 million USD by 2026
"The global IoT solutions market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cybersecurity as a service market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa."
These days many businesses are adopting a market research report…
